These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38599663)

  • 1. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; Keskinkiliç B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The process of prioritization of non-communicable diseases in the global health policy arena.
    Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
    Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
    Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
    PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
    Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
    Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
    Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
    Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored support for national NCD policy and programme implementation: an over-looked priority.
    Jackson-Morris A; Nugent R
    BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32847822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-communicable diseases prevention and control by government ministries in Guyana.
    Roberts KRV; Ventura CAA; de Sousa AFL; Mendes IAC
    Front Public Health; 2024; 12():1369710. PubMed ID: 39386956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and non-communicable diseases in Mexico: a political mapping and stakeholder analysis.
    Orozco-Núñez E; Ojeda-Arroyo E; Cerecer-Ortiz N; Guerrero-López CM; Ramírez-Pérez BM; Heredia-Pi I; Allen-Leigh B; Feeny E; Serván-Mori E
    Health Res Policy Syst; 2024 Apr; 22(1):46. PubMed ID: 38605301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
    Allen LN; Wigley S; Holmer H; Barlow P
    Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curbing the Rise of Noncommunicable Diseases in Uganda: Perspectives of Policy Actors.
    Meghani A; Ssemugabo C; Pariyo G; Hyder AA; Rutebemberwa E; Gibson DG
    Glob Health Sci Pract; 2021 Mar; 9(1):149-159. PubMed ID: 33795366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigating the Rising Burden of Non-Communicable Diseases through Locally Generated Evidence-Lessons from Tanzania.
    Ndumwa HP; Amani DE; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
    Ann Glob Health; 2023; 89(1):77. PubMed ID: 38025921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
    Suzuki M; Webb D; Small R
    Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development of Public Policies to Address Non-communicable Diseases in the Caribbean Country of Barbados: The Importance of Problem Framing and Policy Entrepreneurs.
    Unwin N; Samuels TA; Hassell T; Brownson RC; Guell C
    Int J Health Policy Manag; 2017 Feb; 6(2):71-82. PubMed ID: 28812782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of non-communicable diseases policies in post-apartheid South Africa.
    Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
    Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
    BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.